TERT and hepatocellular carcinoma: HBV-associated HCC often reflects viral–integration–driven oncogenesis (e.g., TERT activation) with distinctive immune contexts, whereas NASH-related HCC exhibits myeloid-skewed, T-cell-dysregulated microenvironments that can blunt immune surveillance.